Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CDXS
#3601
Codexis, Inc.
2.3
7
USD
+3.04%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+3.04%
Mudança mensal
+46.30%
Mudança em 6 meses
-7.78%
Mudança anual
+4.41%
Fechamento anterior
2.3
0
Abrir
2.3
7
Bid
Ask
Mínimo
2.3
7
High
2.3
7
Volume
55
Mercados
Ações
Cuidados de saúde
CDXS
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
64.4 M
65.16 M
65.95 M
70.3 M
82.84 M
90.87 M
—
Valuation ratios
Enterprise value
1.26 B
1.92 B
193.99 M
154.23 M
435.76 M
170.53 M
960.7 M
Price to earnings ratio
—
-94.76
-9.16
-2.79
-5.36
-3.26
-12.23
Price to sales ratio
—
19.27
2.2
3.03
5.9
2.02
13
Price to cash flow ratio
—
-141.52
27.04
-4.04
-7.09
-7.33
-17.61
Price to book ratio
—
12.28
2.11
2.45
5.23
2.81
5.31
Enterprise value to EBITDA ratio
-57.1
-94.77
-6.57
-2.85
-7
-2.66
-13.18
Profitability ratios
Return on assets %
-0.11
-0.09
-0.13
-0.56
-0.44
-0.3
-0.35
Return on equity %
-0.14
-0.13
-0.23
-0.88
-0.98
-0.87
-0.97
Return on invested capital %
-178.54
-105.71
-121.25
-292.59
-347.64
-241.41
-264.45
Gross margin %
80.04
78.47
72.52
81.74
72.55
86.73
316.18
Operating margin %
-34.64
-21.67
-25.17
-97.04
-98.61
-59.3
-548.68
EBITDA margin %
-31.87
-19.35
-21.31
-77.17
-90.44
-52
-506.34
Net margin %
-34.77
-20.31
-24.24
-108.69
-109.99
-62.47
-564.24
Liquidity ratios
Quick ratio
7.34
4.82
3.28
2.53
4.1
3.75
17.1
Current ratio
7.38
4.85
3.32
2.61
4.18
3.82
17.49
Inventory turnover
20.59
20.91
23.85
5.43
7.26
5.16
5.01
Asset turnover
0.37
0.45
0.56
0.36
0.42
0.47
0.52
Solvency ratios
Debt to assets ratio
—
—
—
—
0.4
0.5
2.01
Debt to equity ratio
—
—
—
—
0.89
1.45
5.67
Long term debt to total assets ratio
—
—
—
—
0.19
0.27
1.1
Long term debt to total equity ratio
—
—
—
—
0.43
0.79
3.12
Per share metrics
Operating cash flow per share
—
-0.22
0.17
-0.77
-0.67
-0.22
-0.23
EBIT per share
—
-0.35
-0.53
-1
-0.8
-0.48
-0.49
EBITDA per share
—
-0.31
-0.45
-0.79
-0.73
-0.42
-0.43
Total debt per share
—
—
—
—
0.82
0.84
3.13
Cash per share
—
1.81
1.74
0.96
1
0.9
3.05
Net current asset value per share
—
2.51
2.49
1.37
1.35
1.11
3.94
Tangible book value per share
—
2.5
2.17
1.24
0.88
0.55
2.15
Working capital per share
—
1.99
1.74
0.85
1.02
0.82
3.01
Book value per share
—
2.55
2.22
1.27
0.91
0.58
2.26
Codexis Inc
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Notícias
Benchmark reitera recomendação neutra para ações da Codexis após resultados do 4T
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS)
Stifel reitera recomendação de compra para Codexis com base em guidance sólido para 2026
Cantor Fitzgerald reitera classificação de ações da Codexis após acordo de siRNA
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Codexis (NASDAQ:CDXS)
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates
Lucro da Codexis superou projeções por $0,15; receita supera estimativas
Codexis earnings beat by $0.15, revenue topped estimates
Liquidia Corporation (LQDA) Surpasses Q4 Earnings and Revenue Estimates